Home » MBio Diagnostics, BARDA Team Up on Five-Minute COVID-19 Antibody Test
MBio Diagnostics, BARDA Team Up on Five-Minute COVID-19 Antibody Test
MBio Diagnostics and HHS’ Biomedical Advanced Research and Development Authority (BARDA) have struck a public-private partnership to develop a COVID-19 antibody test designed to take only five minutes.
The test uses whole blood samples to detect anti-SARS-CoV-2 antibodies from active or past infections. The cartridge-based tests can be used in nonprofessional settings, such as a drive-thru clinic or walk-up testing site.
The blood test will detect both immunoglobulin M (IgM) antibodies — the first antibodies the body makes when it fights a new infection — and immunoglobulin G (IgG) antibodies, which show up later.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May